CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $203,529 | -17.8% | 4,484 | +1.7% | 0.00% | -100.0% |
Q2 2023 | $247,465 | +16.9% | 4,408 | -5.8% | 0.00% | 0.0% |
Q1 2023 | $211,676 | +18.6% | 4,680 | +7.5% | 0.00% | – |
Q4 2022 | $178,473 | -38.9% | 4,353 | -2.5% | 0.00% | -100.0% |
Q3 2022 | $292,000 | +9.8% | 4,464 | +2.0% | 0.00% | 0.0% |
Q2 2022 | $266,000 | +12.7% | 4,376 | +16.2% | 0.00% | 0.0% |
Q1 2022 | $236,000 | -14.2% | 3,767 | +8.7% | 0.00% | 0.0% |
Q4 2021 | $275,000 | -12.1% | 3,467 | +23.9% | 0.00% | -50.0% |
Q3 2021 | $313,000 | -30.9% | 2,799 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $453,000 | +13.0% | 2,799 | -15.0% | 0.00% | -33.3% |
Q1 2021 | $401,000 | +16.2% | 3,294 | +46.0% | 0.00% | 0.0% |
Q4 2020 | $345,000 | +38.0% | 2,256 | -24.4% | 0.00% | +50.0% |
Q3 2020 | $250,000 | +13.6% | 2,985 | -0.5% | 0.00% | -33.3% |
Q2 2020 | $220,000 | +98.2% | 2,999 | +14.9% | 0.00% | +50.0% |
Q1 2020 | $111,000 | -7.5% | 2,610 | +29.7% | 0.00% | 0.0% |
Q4 2019 | $120,000 | -20.0% | 2,013 | -44.9% | 0.00% | 0.0% |
Q3 2019 | $150,000 | +4.2% | 3,655 | +19.4% | 0.00% | 0.0% |
Q2 2019 | $144,000 | -4.6% | 3,060 | -27.5% | 0.00% | -33.3% |
Q1 2019 | $151,000 | +34.8% | 4,220 | +5.8% | 0.00% | 0.0% |
Q4 2018 | $112,000 | +13.1% | 3,987 | +79.4% | 0.00% | +50.0% |
Q3 2018 | $99,000 | – | 2,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |